Latham & Watkins has advised Eleusis on the deal.Eleusis, a life science company dedicated to unlocking the full therapeutic potential of psychedelics, announced the sale of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
